A Review of Topical Cyclosporine A Formulations—A Disease-Modifying Agent for Keratoconjunctivitis Sicca

A Review of Topical Cyclosporine A Formulations—A Disease-Modifying Agent for Keratoconjunctivitis Sicca

Gary W Jerkins,1 Guruprasad R Pattar,2 Shane R Kannarr3 1Advancing Vision Research, Nashville, TN, USA; 2The Eye Care Institute, Louisville, KY, USA; 3Kannarr Eye Care, Pittsburg, KS, USACorrespondence: Gary W JerkinsAdvancing Vision Associates, 4306 Harding Pike, Nashville, TN 37205, USATel +1 615...

Full description

Bibliographic Details
Main Authors:	Jerkins GW, Pattar GR, Kannarr SR
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-02-01
Series:	Clinical Ophthalmology
Subjects:	cyclosporine a keratoconjunctivitis sicca emulsion nanomicelles otx-101
Online Access:	https://www.dovepress.com/a-review-of-topical-cyclosporine-a-formulationsmdasha-disease-modifyin-peer-reviewed-article-OPTH

Similar Items

Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca
by: Sheppard J, et al.
Published: (2021-01-01)

A Review of the Mechanism of Action of Cyclosporine A: The Role of Cyclosporine A in Dry Eye Disease and Recent Formulation Developments
by: Periman LM, et al.
Published: (2020-12-01)

Changes in tear protein profile in dogs with keratoconjunctivitis sicca following topical treatment using cyclosporine A
by: Metita Sussadee, et al.
Published: (2021-06-01)

Cyclosporine A (CsA) treatment of chronic autoimune-mediated keratoconjunctivitis sicca in dogs
by: Hadži-Milić M., et al.
Published: (2013-01-01)

Tear ferning in normal dogs and dogs with keratoconjunctivitis sicca
by: David Williams, et al.
Published: (2017-09-01)

Efficacy and safety of 0.05% micellar nano-particulate (MNP) cyclosporine ophthalmic emulsion in the treatment of moderate-to-severe keratoconjunctivitis sicca: a 12-week, multicenter, randomized, active-controlled trial
by: A Tarakeswara Rao, et al.
Published: (2023-03-01)

Efficacy and safety of pranoprofen in the treatment of keratoconjunctivitis sicca
by: Zhen Chen, et al.
Published: (2018-02-01)

Real-world treatment patterns of OTX-101 ophthalmic solution, cyclosporine ophthalmic emulsion, and lifitegrast ophthalmic solution in patients with dry eye disease: a retrospective analysis
by: Paul Karpecki, et al.
Published: (2023-11-01)

Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease
by: de Oliveira RC, et al.
Published: (2019-07-01)

Effect of Oral Choline Alfoscerate on Patients with Keratoconjunctivitis Sicca
by: Jin Ju Choi, et al.
Published: (2020-05-01)

Topical ocular 0.1% cyclosporine A cationic emulsion in dry eye disease patients with severe keratitis: experience through the French early-access program
by: Pisella P, et al.
Published: (2018-02-01)

Comparison of topical 0.03% tacrolimus and homologous injectable platelet-rich plasma in the treatment of keratoconjunctivitis sicca in dogs
by: Giovana José Garcia Estanho, et al.
Published: (2023-01-01)

A 41-year-old Female Presenting with Sicca Syndrome
by: Laurence Ian Tan, et al.
Published: (2008-12-01)

Apricot Kernel Extract and Amygdalin Inhibit Urban Particulate Matter-Induced Keratoconjunctivitis Sicca
by: Soo-Wang Hyun, et al.
Published: (2019-02-01)

Topical applications of allogeneic adipose-derived mesenchymal stem cells ameliorate the canine keratoconjunctivitis sicca
by: Li-Ning Wei, et al.
Published: (2022-06-01)

Comparison of Efficacy of Two Different Topical 0.05% Cyclosporine A Formulations in the Treatment of Adenoviral Keratoconjunctivitis-Related Subepithelial Infiltrates
by: Betül N. Bayraktutar, et al.
Published: (2016-03-01)

Comparison of hyaluronic acid-containing topical eye drops with carbomer-based topical ocular gel as a tear replacement in canine keratoconjunctivitis sicca: A prospective study in twenty five dogs
by: David Williams, et al.
Published: (2012-12-01)

Managing Dry Eye Disease and Facilitating Realistic Patient Expectations: A Review and Appraisal of Current Therapies
by: Shen Lee B, et al.
Published: (2020-01-01)

Systemic Treatment of Immune-Mediated Keratoconjunctivitis Sicca with Allogeneic Stem Cells Improves the Schirmer Tear Test Score in a Canine Spontaneous Model of Disease
by: Manuel Hermida-Prieto, et al.
Published: (2021-12-01)

Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease
by: Burade V, et al.
Published: (2020-09-01)

Puntoplastia en el tratamiento de la queratoconjuntivitis seca Punctum surgery for the treatment of keratoconjunctivitis sicca
by: Nereyda G. Martínez Suárez, et al.
Published: (2008-12-01)

Dry-eye syndrome in Shih Tzu dog: Ocular surface clinical and morphological aspects in the different stages of keratoconjunctivitis sicca
by: Andre R. Fayad, et al.
Published: (2023-07-01)

A Case of Shield Ulcer Due to Vernal Keratoconjunctivitis
by: Dilek Özkaya, et al.
Published: (2021-08-01)

Dry Eye Syndrome and Sicca Complex are Commonly Found in Patients with Postural Orthostatic Tachycardia Syndrome
by: Ho DS, et al.
Published: (2020-11-01)

Stability and Safety Traits of Novel Cyclosporine A and Tacrolimus Ophthalmic Galenic Formulations Involved in Vernal Keratoconjunctivitis Treatment by a High-Resolution Mass Spectrometry Approach
by: Daniele Giovanni Ghiglioni, et al.
Published: (2020-04-01)

Changes in tear production in a dog with keratoconjunctivitis sicca for a year after inevitable nictitating membrane gland resection due to suspicion of a malignant tumour
by: Hyun‐Jeong Yoon, et al.
Published: (2022-11-01)

Cicatricial keratoconjunctivitis associated with lichen planus
by: Huang, Susan, et al.
Published: (2015-10-01)

Efficacy, Safety and Steroid-sparing Effect of Topical Cyclosporine A 0.05% for Vernal Keratoconjunctivitis in Indian Children
by: Arkendu Chatterjee, et al.
Published: (2019-10-01)

Clinical Outcomes of Topical 0.1% Ciclosporin Cationic Emulsion Used on Label in Children with Vernal Keratoconjunctivitis
by: Giuseppe Giannaccare, et al.
Published: (2023-04-01)

Effect and Mechanisms of Medicinal Plants on Dry Eye Disease: A Systematic Review
by: Ezatollah Memarzadeh, et al.
Published: (2018-09-01)

Incremental Concentrations of Tacrolimus Eye Drops as a Strategy for the Management of Severe Vernal Keratoconjunctivitis
by: Maan Abdullah Albarry, et al.
Published: (2022-03-01)

Desiccation Induced Conjunctival Monocyte Recruitment and Activation - Implications for Keratoconjunctivitis
by: Jehan Alam, et al.
Published: (2021-07-01)

Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis
by: Okumus Seydi, et al.
Published: (2012-08-01)

Cyclosporine A Delivery Platform for Veterinary Ophthalmology—A New Concept for Advanced Ophthalmology
by: Martyna Padjasek, et al.
Published: (2022-10-01)

Eye drop emulsion containing 0.1% cyclosporin (1 mg/mL) for the treatment of severe vernal keratoconjunctivitis: an evidence-based review and place in therapy
by: Nebbioso M, et al.
Published: (2019-07-01)

FEATURES OF CLINICAL COURSE AND COMBINED THERAPY OF VERNAL KERATOCONJUNCTIVITIS (A CASE REPORT)
by: D. Y. Maychuk, et al.
Published: (2017-01-01)

Dry Eye Syndrome
by: Mohammad-Ali Javadi, et al.
Published: (2011-01-01)

Analysis of tear production in patients with periocular alopecia: a retrospective study between the years 2008 and 2012 at the Veterinary Hospital of the Londrina State University
by: Maria Fernanda de Souza Ferraz, et al.
Published: (2014-09-01)

MICROBIOTA CONJUNTIVAL EM CÃES CLINICAMENTE SADIOS E CÃES COM CERATOCONJUNTIVITE SECA
by: Arianne Pontes Oria, et al.
Published: (2013-12-01)

Comparison of 0.2% and 0.18% hyaluronate eye drops in patients with moderate to severe dry eye with keratitis or keratoconjunctivitis
by: Groß D, et al.
Published: (2017-04-01)